Vaccine-induced rabies case in a cow (Bos taurus): Molecular characterisation of vaccine strain in brain tissue

Vaccine

Volumn 34, Issue 41, 2016, Pages 5021-5025

  Vuta, Vlad ^a,b   Picard Meyer, Evelyne ^c   Robardet, Emmanuelle ^c   Barboi, Gheorghe ^a   Motiu, Razvan ^a   Barbuceanu, Florica ^a,b   Vlagioiu, Constantin ^b   Cliquet, Florence ^c  

^a Institute for Diagnosis and Animal Health   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c FRENCH AGENCY FOR FOOD   (France)

Author keywords

Fox; Pathogenicity; Rabies; SAD B19; Sequencing; Vaccine

Indexed keywords

RABIES VACCINE; VIRUS RNA; LIVE VACCINE;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; GENE SEQUENCE; HEALTH PROGRAM; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; RABIES; RABIES VIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; ROMANIA; STRAIN DIFFERENCE; TAURINE CATTLE; VACCINATION; VIRUS CHARACTERIZATION; VIRUS ISOLATION; WESTERN EUROPEAN; ANIMAL; BOVINE; BRAIN; CHEMICALLY INDUCED; GENETICS; ISOLATION AND PURIFICATION; PHYLOGENY; VIROLOGY;

ANIMALS; BRAIN; CATTLE; PHYLOGENY; RABIES; RABIES VACCINES; RABIES VIRUS; RNA, VIRAL; ROMANIA; VACCINES, ATTENUATED;

EID: 84990066641     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.08.013     Document Type: Article

References (32)

1. [1] Schnell, M.J., McGettigan, J.P., Wirblich, C., Papaneri, A., The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol 8 (2010), 51–61.
2. [2] WHO, WHO expert consultation on rabies. Second report. WHO technical report series 982. 2013, World Health Organization, Geneva.
3. [3] Robardet, E., Picard-Meyer, E., Dobrostana, M., Jaceviciene, I., Mahar, K., Muizniece, Z., et al. Rabies in the Baltic States: decoding a process of control and elimination. PLoS Negl Trop Dis, 10, 2016, e0004432.
4. [4] Panel, EFSA AHAW, Update on oral vaccination of foxes and raccoon dogs against rabies. Scientific panel on animal health and welfare (AHAW). EFSA J, 13, 2015, 70.
5. [5] Cliquet, F., Picard-Meyer, E., Mojzis, M., Dirbakova, Z., Muizniece, Z., Jaceviciene, I., et al. In-depth characterization of live vaccines used in Europe for oral rabies vaccination of wildlife. PLoS ONE, 10, 2015, e0141537.
6. [6] Europan Commission, Final outcome of the evaluation procedure of eradication, control and surveillance programmes submitted by the MSs for Union financial contribution for 2016 and following years. 2016, PAFF Committee Available at: .
7. [7] Meslin, F.X., Kaplan, M.M., Koprowski, H., Laboratory techniques in rabies. 4th ed., 1996, World Health Organization, Geneva.
8. [8] Robardet, E., Andrieu, S., Bruun Rasmussen, T., Dobrostana, M., Horton, D.L., Hostnik, P., et al. Comparative assay of fluorescent antibody test results among twelve European National Reference Laboratories using various anti-rabies conjugates. J Virol Methods 191 (2013), 88–94.
9. [9] Picard-Meyer, E., Peytavin de Garam, C., Schereffer, J.L., Marchal, C., Robardet, E., Cliquet, F., Cross-platform evaluation of commercial real-time SYBR green RT-PCR kits for sensitive and rapid detection of European bat lyssavirus type 1. Biomed Res Int, 2015, 839518, 10.1155/2015/83951.
10. [10] Picard-Meyer, E., Bruyere, V., Barrat, J., Tissot, E., Barrat, M.J., Cliquet, F., Development of a hemi-nested RT-PCR method for the specific determination of European Bat Lyssavirus 1. Comparison with other rabies diagnostic methods. Vaccine 22 (2004), 1921–1929.
11. [11] Heaton, P.R., Johnstone, P., McElhinney, L.M., Cowley, R., O'Sullivan, E., Whitby, J.E., Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses. J Clin Microbiol 35 (1997), 2762–2766.
12. [12] Bourhy, H., Kissi, B., Audry, L., Smreczak, M., Sadkowska-Todys, M., Kulonen, K., et al. Ecology and evolution of rabies virus in Europe. J Gen Virol 80 (1999), 2545–2557.
13. [13] Pant, G.R., Lavenir, R., Wong, F.Y., Certoma, A., Larrous, F., Bhatta, D.R., et al. Recent emergence and spread of an Artic-related phylogenetic lineage of rabies virus in Nepal. PLoS Negl Trop Dis, 7, 2013, e2560.
14. [14] Hostnik, P., Picard-Meyer, E., Rihtaric, D., Toplak, I., Cliquet, F., Vaccine-induced rabies in a red fox (Vulpes vulpes): isolation of vaccine virus in brain tissue and salivary glands. J Wildl Dis 50 (2014), 397–401.
15. [15] Muller, T., Bätza, H.J., Beckert, A., Bunzenthal, C., Cox, J.H., Freuling, C.M., et al. Analysis of vaccine-virus-associated rabies cases in red foxes (Vulpes vulpes) after oral rabies vaccination campaigns in Germany and Austria. Arch Virol 154 (2009), 1081–1091.
16. [16] Geue, L., Schares, S., Schnick, C., Kliemt, J., Beckert, A., Freuling, C., et al. Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife. Vaccine 26 (2008), 3227–3235.
17. [17] European Commission. Final report on a mission carried out in Germany from 30 March to 6 April 2006 in order to evaluate the rabies eradication programme. DG(SANCO)/8213/2006 – MR Final; 2006. 17 p.
18. [18] OIE. Rabies, Manual of diagnostic tests and vaccines for terrestrial animals (mammals, birds and bees), online version. 2013, OIE, Paris Available at: .
19. [19] Cliquet, F., Robardet, E., Picard-Meyer, E., Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination. Antiviral Res 100 (2013), 84–89.
20. [20] Institute for State control of veterinary biologicals and medicines. Marketing authorization VMPs list – Lysvulpen; 2009. Available at: < http://www.uskvbl.cz/en/authorisation-a-approval/marketing-authorisation-of-vmps/list-of-vmps/currently-authorised-vmp/vmp-details?Id=0910f7c780096011>.
21. [21] EDQM, Rabies vaccine (live, oral) for foxes and raccoon dogs. European Pharmacopoeia. 8.0 ed., 2014, Council of Europe – EDQM, Strasbourg, 1011–1012.
22. [22] EDQM, Rabies vaccine (inactivated) for veterinary use. Mongraph 0451. European Pharmacopoeia. 7th ed., 2013, Council of Europe, Strasbourg, 1008–1011.
23. [23] European medicines Agency. Harmonisation of criteria to waive target animal batch safety testing for live vaccines for veterinary use. VICH GL55 2016. 11 p.
24. [24] Esh, J.B., Cunningham, J.G., Wiktor, T.J., Vaccine-induced rabies in four cats. J Am Vet Med Assoc 180 (1982), 1336–1339.
25. [25] Erlewein, D.L., Post-vaccinal rabies in a cat. Feline Practice 11 (1981), 16–21.
26. [26] Vos, A., Neubert, A., Aylan, O., Schuster, P., Pommerening, E., Muller, T., et al. An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species. Epidemiol Infect 123 (1999), 165–175.
27. [27] Rupprecht, C.E., Charlton, K.M., Artois, M., Casey, G.A., Webster, W.A., Campbell, J.B., et al. Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis). J Wildl Dis 26 (1990), 99–102.
28. [28] Bingham, J., Foggin, C.M., Gerber, H., Hill, F.W., Kappeler, A., King, A.A., et al. Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus). Vet Rec 131 (1992), 55–56.
29. [29] Wandeler, A.I., Capt, S., Kappeler, A., Hauser, R., Oral immunization of wildlife against rabies: concept and first field experiments. Rev Infect Dis 10 (1988), S649–S653.
30. [30] Vanek, E., Wodak, E., Revilla-Fernandez, S., Bagó, Z., Schildorfer, H., Hoeflechner, A., et al. Fox rabies in Carinthia, Austria: a case report. Rabies Bull Eur, 28, 2004, 9.
31. [31] Fehlner-Gardiner, C., Nadin-Davis, S., Armstrong, J., Muldoon, F., Bachmann, P., Wandeler, A., ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989–2004. J Wildl Dis 44 (2008), 71–85.
32. [32] Mahl, P., Cliquet, F., Guiot, A.L., Niin, E., Fournials, E., Saint-Jean, N., et al. Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review. Vet Res, 45, 2014, 77.